A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples